Chemoinformaics analysis of 9-HYDROXY-4-METHOXYFURO[3,2-G]CHROMEN-7-ONE
Molecular Weight | 232.191 | nRot | 1 |
Heavy Atom Molecular Weight | 224.127 | nRig | 16 |
Exact Molecular Weight | 232.037 | nRing | 3 |
Solubility: LogS | -3.214 | nHRing | 2 |
Solubility: LogP | 1.918 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 3 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 25 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 1 |
nHetero | 5 | No. of Aromatic Hetero Cycles | 2 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 13 |
No. of Oxygen atom | 5 | No. of Arom Bond | 15 |
nHA | 5 | APOL | 29.3843 |
nHD | 1 | BPOL | 14.1017 |
QED | 0.651 |
Synth | 2.686 |
Natural Product Likeliness | 1.565 |
NR-PPAR-gamma | 0.875 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.008 |
Pgp-sub | 0.004 |
HIA | 0.02 |
CACO-2 | -4.872 |
MDCK | 0.0000257 |
BBB | 0.016 |
PPB | 0.82208 |
VDSS | 0.813 |
FU | 0.153437 |
CYP1A2-inh | 0.977 |
CYP1A2-sub | 0.886 |
CYP2c19-inh | 0.198 |
CYP2c19-sub | 0.093 |
CYP2c9-inh | 0.529 |
CYP2c9-sub | 0.674 |
CYP2d6-inh | 0.774 |
CYP2d6-sub | 0.441 |
CYP3a4-inh | 0.507 |
CYP3a4-sub | 0.165 |
CL | 13.542 |
T12 | 0.779 |
hERG | 0.013 |
Ames | 0.171 |
ROA | 0.911 |
SkinSen | 0.524 |
Carcinogencity | 0.85 |
EI | 0.21 |
Respiratory | 0.787 |
NR-Aromatase | 0.738 |
Antiviral | No |
Prediction | 0.570988 |